New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Top Cited Papers
Open Access
- 1 March 2017
- Vol. 93 (6), 1296-1313
- https://doi.org/10.1016/j.neuron.2017.02.005
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1DP3DK094292, 1R24082841)
- Engineering Research Centers
- Deutsche Forschungsgemeinschaft (SPP-1757)
- Horizon 2020 (633491)
- Novo Nordisk Fonden (095698z/11/z, NNF14OC0011633)
This publication has 176 references indexed in Scilit:
- Oligodendroglia metabolically support axons and contribute to neurodegenerationNature, 2012
- Glycolytic oligodendrocytes maintain myelin and long-term axonal integrityNature, 2012
- Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative–nitrosative stressFree Radical Biology & Medicine, 2012
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural MechanismsNeuron, 2012
- Insulin resistance in the nervous systemTrends in Endocrinology & Metabolism, 2012
- Axon degeneration: Molecular mechanisms of a self-destruction pathwayThe Journal of cell biology, 2012
- The identification of gene expression profiles associated with progression of human diabetic neuropathyBrain, 2011
- Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromesPain, 2010
- In vivo silencing of the CaV3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathyPain, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009